Joaquin Duato is Chairman/CEO of Johnson & Johnson (JNJ). The company reported total compensation of $32,758,111 for fiscal year 2025.
| Salary | $1,600,000 |
|---|---|
| Bonus | $0 |
| Stock awards | $15,028,948 |
| Option awards | $5,927,995 |
| Non-equity incentive plan | $4,298,700 |
| Pension and non-qualified deferred compensation | $5,301,237 |
| All other compensation | $601,231 |
| Total | $32,758,111 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure Johnson & Johnson filed March 11, 2026, accession 0000200406-26-000063.
| Fiscal year | Role | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|---|
| FY2025 | Chairman/CEO | $1,600,000 | $0 | $15,028,948 | $5,927,995 | $4,298,700 | $5,301,237 | $601,231 | $32,758,111 |
| FY2024 | Chairman of the Board and Chief Executive Officer | $1,600,000 | $0 | $10,787,159 | $4,919,991 | $3,981,050 | $2,694,000 | $320,160 | $24,302,360 |
| FY2023 | Chairman & Chief Executive Officer | $1,584,615 | — | $11,182,143 | $4,796,990 | $4,378,500 | $6,213,000 | $241,992 | $28,397,240 |
| FY2022 | Chairman & Chief Executive Officer | $1,490,962 | — | $5,940,829 | $2,318,959 | $3,079,750 | $0 | $268,987 | $13,099,487 |
| FY2021 | Chairman & Chief Executive Officer | $1,030,000 | — | $7,001,281 | $2,393,998 | $2,319,450 | $875,767 | $184,796 | $13,805,292 |
Totals as disclosed in each year's own compensation disclosure for Johnson & Johnson.
| Peer-group chief executive median | $24,846,826 |
|---|---|
| Difference from that median | $7,911,285 |
| Percentile within the disclosed peer group | 77th |
| Peers with a disclosed figure | 13 |
Medians and percentiles are computed across the peer group Johnson & Johnson discloses in its own compensation disclosure.
| Named executive officer | Role | FY2025 total |
|---|---|---|
| Joaquin Duato this page | Chairman/CEO | $32,758,111 |
| Joseph Wolk | EVP, CFO | $14,405,442 |
| Jennifer Taubert | EVP, WWC Innovative Medicine | $14,030,063 |
| John Reed | EVP, Innovative Medicine, R&D | $12,214,062 |
| Tim Schmid | EVP, WWC, MedTech | $9,336,765 |
The company's named executive officers for fiscal year 2025, and what it reported for each. See the full Johnson & Johnson compensation brief.
Joaquin Duato's compensation sits inside Johnson & Johnson's full executive and board picture — the peer group, pay against peers, incentive design and the board itself.